A Study of WX390 Combined With Toripalimab in Patients With Advanced Solid Tumors
Clinical trial NCT06117566 · RECRUITING
Trial details
- NCT number
- NCT06117566
- Sponsor
- Shanghai Jiatan Pharmatech Co., Ltd
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-18
- Primary completion
- 2025-11-09
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.